Get the Stockscreener App
19.77
0.99%
-0.275
Overview
News
Price History
Option Chain
Why BCS Down?
Discussions
Forecast
Stock Split
Dividend History
Barclays Plc Adr stock is traded at $19.77, with a volume of 10.97M.
It is down -0.99% in the last 24 hours and up +6.79% over the past month.
Barclays is a universal bank headquartered in the United Kingdom. It operates via five principal segments; UK (retail), UK corporate bank, private bank and wealth management, investment bank, and US consumer bank. In its UK segment, the bank provides current accounts, mortgages, savings and investment management services, credit cards, and business banking services to retail clients and small and medium-size enterprises. The international segment includes a corporate bank offering banking solutions to large corporates, a bulge-bracket global investment bank, and a credit card and payments business.
See More
Previous Close:
$20.05
Open:
$19.96
24h Volume:
10.97M
Relative Volume:
0.72
Market Cap:
$69.95B
Revenue:
$34.41B
Net Income/Loss:
$8.41B
P/E Ratio:
10.02
EPS:
1.9737
Net Cash Flow:
$210.02B
1W Performance:
+2.01%
1M Performance:
+6.79%
6M Performance:
+34.13%
1Y Performance:
+65.57%
1-Day Range:
$19.79
$20.07
1-Week Range:
$19.30
$20.07
52-Week Range:
$10.22
$20.07
Barclays Plc Adr Stock (BCS) Company Profile
Compare BCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BCS
Barclays Plc Adr
|
19.79 | 68.46B | 34.41B | 8.41B | 210.02B | 1.9737 |
|
JPM
Jpmorgan Chase Co
|
298.24 | 820.17B | 175.69B | 56.53B | -139.69B | 19.49 |
|
BAC
Bank Of America Corp
|
47.90 | 358.67B | 104.52B | 28.07B | 4.55B | 3.42 |
|
WFC
Wells Fargo Co
|
81.61 | 267.52B | 81.72B | 20.58B | 4.12B | 5.84 |
|
HSBC
Hsbc Holdings Plc Adr
|
61.24 | 224.54B | 72.00B | 20.72B | 153.10B | 5.45 |
|
RY
Royal Bank Of Canada
|
129.45 | 183.97B | 44.47B | 13.04B | 56.66B | 8.9892 |
Barclays Plc Adr Stock (BCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-25 | Downgrade | Citigroup | Buy → Neutral |
| Mar-04-25 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Oct-08-24 | Initiated | Goldman | Buy |
| Sep-05-24 | Initiated | Kepler | Buy |
| May-09-24 | Initiated | Deutsche Bank | Buy |
| Oct-26-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-26-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-08-23 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| May-12-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Dec-14-22 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Dec-06-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-22-22 | Upgrade | Citigroup | Neutral → Buy |
| Mar-29-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-28-22 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-07-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-30-21 | Upgrade | Redburn | Neutral → Buy |
| Mar-16-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Mar-12-21 | Upgrade | Goldman | Neutral → Buy |
| Nov-10-20 | Downgrade | Investec | Buy → Hold |
| Jul-10-20 | Upgrade | Investec | Hold → Buy |
| Mar-03-20 | Downgrade | Societe Generale | Buy → Hold |
| Feb-11-20 | Resumed | Credit Suisse | Neutral |
| Nov-26-19 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Sep-05-19 | Upgrade | Keefe Bruyette | Underperform → Mkt Perform |
| Aug-21-19 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
| Apr-18-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-01-18 | Upgrade | Berenberg | Hold → Buy |
| Jun-19-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Apr-16-18 | Upgrade | Jefferies | Hold → Buy |
| Mar-29-18 | Upgrade | Investec | Hold → Buy |
| Mar-20-18 | Downgrade | Investec | Buy → Hold |
| Mar-08-18 | Upgrade | Goldman | Sell → Neutral |
| Jan-11-18 | Downgrade | Keefe Bruyette | Mkt Perform → Underperform |
| Jan-10-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-15-17 | Downgrade | Investec | Buy → Hold |
| Nov-20-17 | Upgrade | BofA/Merrill | Underperform → Buy |
| Oct-31-17 | Upgrade | Keefe Bruyette | Underperform → Mkt Perform |
| Oct-20-17 | Upgrade | Berenberg | Sell → Hold |
View All
Barclays Plc Adr Stock (BCS) Latest News
Liberty Energy (NYSE:LBRT) Given New $14.00 Price Target at Barclays - Defense World
Brown & Brown (NYSE:BRO) Price Target Lowered to $108.00 at Barclays - Defense World
Carter’s (NYSE:CRI) Price Target Lowered to $22.00 at Barclays - Defense World
Barclays Issues Positive Forecast for PTC Therapeutics (NASDAQ:PTCT) Stock Price - Defense World
Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Receives $33.83 Average PT from Analysts - Defense World
Strategy Closes $2.52B STRC IPO, Acquires 21,021 Bitcoin At $117K Each - Benzinga
Barclays' Q2 Earnings Increase Y/Y On Growth In Revenues - Barchart.com
Barclays ADR earnings beat by $0.59, revenue fell short of estimates - Investing.com Nigeria
Is Barclays PLC ADR (BCS) a Strong Buy Amid Cost-Cutting and Resilient Earnings? - AInvest
Barclays' Strategic Reinvention: Unlocking Earnings and Shareholder Value in the Post-Tesco Bank Era - AInvest
19 Newly Overvalued Stocks for the Week - Morningstar
Barclays Set To Report Q2 Earnings: Here's What You Should Know - Barchart.com
Brokerages Set Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) PT at $54.28 - Defense World
Shell PLC Unsponsored ADR (NYSE:SHEL) Shares Bought by Advisors Preferred LLC - MarketBeat
Phoenix Financial Ltd. Sells 58,975 Shares of Shell PLC Unsponsored ADR (NYSE:SHEL) - MarketBeat
Accretive Wealth Partners LLC Takes $293,000 Position in Shell PLC Unsponsored ADR (NYSE:SHEL) - MarketBeat
Cerity Partners LLC Makes New $420,000 Investment in Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) - Defense World
Cerity Partners LLC Invests $471,000 in Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) - Defense World
Dollar Tree Earnings Preview: What To Expect - Barchart.com
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Shares Acquired by Envestnet Asset Management Inc. - Defense World
J.W. Cole Advisors Inc. Has $2.08 Million Stake in Shell PLC Unsponsored ADR (NYSE:SHEL) - MarketBeat
Logitech International S.A. (NASDAQ:LOGI) Shares Purchased by Envestnet Asset Management Inc. - Defense World
OneAscent Financial Services LLC Acquires New Stake in Shell PLC Unsponsored ADR (NYSE:SHEL) - MarketBeat
Shell PLC Unsponsored ADR (NYSE:SHEL) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) CEO Saurabh Saha Sells 55,000 Shares of Stock - Defense World
Regency Capital Management Inc. DE Sells 31,605 Shares of Shell PLC Unsponsored ADR (NYSE:SHEL) - MarketBeat
Shell PLC Unsponsored ADR (NYSE:SHEL) Stake Raised by Kingsview Wealth Management LLC - MarketBeat
Genmab A/S Sponsored ADR (NASDAQ:GMAB) Shares Purchased by Envestnet Asset Management Inc. - Defense World
Equity Investment Corp Has $75.43 Million Stock Holdings in Shell PLC Unsponsored ADR (NYSE:SHEL) - MarketBeat
Barclays warns: ’Negative summer seasonality’ is looming - Investing.com India
Barclays Outpaces The Market, But Risks Still Linger - Finimize
Hollencrest Capital Management Grows Position in Shell PLC Unsponsored ADR (NYSE:SHEL) - MarketBeat
Barclays discloses 1.36% stake in Dalata Hotel Group - Investing.com India
PACS Group, Inc. (NYSE:PACS) Shares Sold by Teacher Retirement System of Texas - Defense World
Citi downgrades Barclays stock to Neutral on balanced risk-reward outlook - Investing.com India
Barclays favors Rogers in struggling Canadian telecom sector - Investing.com India
Shell PLC Unsponsored ADR (NYSE:SHEL) Shares Purchased by Cullen Frost Bankers Inc. - MarketBeat
Chinese oil demand remains resilientBarclays - Investing.com India
Bridgewater Advisors Inc. Purchases New Holdings in Shell PLC Unsponsored ADR (NYSE:SHEL) - MarketBeat
European Q2 earnings beats expected, but beware of positioning gapBarclays - Investing.com India
Barclays downgrades Outokumpu stock rating to Underweight on European stainless steel concerns - Investing.com India
Barclays fined £42 million by UK’s FCA for poor financial crime risk handling - Investing.com India
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Average Rating of “Buy” by Analysts - Defense World
Investors Take Advantage Of 1.30% Gain In Barclays plc ADR (NYSE: BCS) - Stocksregister
Mexican stock market downgraded by Barclays as tariff risks persist - Investing.com India
L’Oreal stock rating downgraded by Barclays on growth concerns - Investing.com India
Unitedhealth Group Inc (UNH) Stock: Exploring a Year of Highs, Lows, and Trading Volume - investchronicle.com
EOSE’s Stock Market Adventure: 144.66% YTD Growth Amidst Volatility - investchronicle.com
Barclays cuts rating on Inapp as it sees slowdown in revenue growth - Investing.com India
SMCI’s Market Flip-Flop: Exploring the Volatility of 2025 Performance - investchronicle.com
Kraft Heinz stock steady as Barclays maintains Equalweight rating amid breakup plans - Investing.com India
Barclays Plc Adr Stock (BCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):